 BIOLASE, Inc. NASDAQ: BIOL, the global leader in dental lasers, today announced that it has entered into a securities purchase agreement with institutional investors to purchase approximately 6.9 million of its common stock in a registered direct offering priced at-the-market under Nasdaq rules and warrants to purchase common stock in a concurrent private placement. The combined purchase price for one share of common stock and warrant to purchase one share of common stock will be 0.64. 